Ipca launches new anti-pain drug Etova

MUMBAI: Pharma major Ipca Laboratories Ltd on Wednesday announced the launch of the country's first Etodoloc, called Etova, a new-generation pain manager.

Etova is a safe and effective pain-relieving agent and is also FDA-approved, a company release said here.

Pain management is a growing area of activity with increased incidence of dental pain, arthritis pain, lower back pain, injuries and post surgical pain.

Ipca was the first in India to introduce other pain managers like Zerodol, Movon and also hydroxychloroquine. With the launch of Etova, Ipca will be consolidating its position in the pain management category.